Literature DB >> 8732901

Cryptogenic hepatitis masking the diagnosis of ornithine transcarbamylase deficiency.

E Zammarchi1, M A Donati, L Filippi, M Resti.   

Abstract

We describe three children with transaminase elevations and hepatic insufficiency who were given the diagnosis of cryptogenic hepatitis after the more common viral and metabolic diseases of the liver had been excluded. However, further laboratory investigations showed hyperammonemia, low blood urea levels, elevated plasma glutamine levels, and low citrulline levels. Urinary excretion of orotic acid was higher than normal, with absent urinary homocitrulline and normal fractional tubular reabsorption of lysine, ornithine, and arginine. These findings suggest the diagnosis of ornithine transcarbamylase deficiency. We emphasize the importance of investigating possible urea cycle disorders by determining ammonia plasma levels, both at baseline and after a protein load; urinary and plasma amino acids; and urinary orotic acid in all patients with liver disease of indeterminate etiology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8732901     DOI: 10.1097/00005176-199605000-00007

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  4 in total

1.  Acute liver dysfunction with delayed peak of serum aminotransferase levels as a presentation of ornithine transcarbamylase deficiency in females.

Authors:  Kathryn Clarkston; Joy Lee; Sarah Donoghue; Heidi Peters; Hernan Eiroa; Amit A Shah; Kathleen Loomes; Jessica Wen; Mark Oliver; Winita Hardikar; Carlos E Prada; Akihiro Asai
Journal:  Am J Med Genet A       Date:  2020-12-24       Impact factor: 2.802

2.  Liver failure with coagulopathy, hyperammonemia and cyclic vomiting in a toddler revealed to have combined heterozygosity for genes involved with ornithine transcarbamylase deficiency and Wilson disease.

Authors:  Valerie Mira; Richard G Boles
Journal:  JIMD Rep       Date:  2011-09-22

3.  Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency.

Authors:  James M Wilson; Oleg A Shchelochkov; Renata C Gallagher; Mark L Batshaw
Journal:  Mol Genet Metab       Date:  2011-11-07       Impact factor: 4.797

4.  Significant hepatic involvement in patients with ornithine transcarbamylase deficiency.

Authors:  Renata C Gallagher; Christina Lam; Derek Wong; Stephen Cederbaum; Ronald J Sokol
Journal:  J Pediatr       Date:  2014-01-30       Impact factor: 4.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.